spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Sterling Pharma Solutions launches following management buyout

Sterling Pharma Solutions

New CDMO formed as a result of buyout of UK-based site

UK-based Sterling Pharma Solutions has formed as an independent contract development and manufacturing organisation (CDMO) following a management buyout (MBO) of the UK based Dudley site.

Formerly operating as Shasun Pharma Solutions within Strides Shasun, the process of divesting the business to the current management team was completed in September 2016.

Following the MBO, the newly divested business has been rebranded and launched as Sterling Pharma Solutions. The CDMO will specialise in delivering API development and manufacturing solutions to support global pharmaceutical companies across the entire product lifecycle.

The management team will be led by Kevin Cook as CEO. Kevin joined the Dudley site in 1993. He says: “We are delighted to complete the MBO and excited about building a global API services business with roots in the north east of England. Our offering is compelling as we can take projects from proof of concept to commercial scale manufacture all on one site. We also have the capabilities to handle the most hazardous chemical processes safely.

“We have experienced significant growth in the US and Europe in recent years and believe the extensive capabilities at our site, coupled with our heritage in the API services sector, provide us with an excellent foundation to become the leading partner and provider of API services to the pharmaceutical industry.”

Sterling Pharma Solutions’ site in Dudley, UK, has been in existence for 47 years and is the UK’s largest provider of API development and manufacturing services to the pharmaceutical industry.
phone +44 (0) 191 250 0471
email enquiries@sterlingpsl.com
web www.sterlingpharmasolutions.com
email Sterling Place, Dudley Cramlington, Northumberland, NE23 7QG, United Kingdom
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Countdown to the UK’s leading production line event begins

The manufacturing sector has just achieved its longest period of expansion since 1968, boosted by global economic growth and the weakened pound, while early signs reveal that Britain’s manufacturers are on track to outpace the rest of the economy – setting the year on a strong path for growth.
More info >>


White Papers

Syringe siliconization

Gerresheimer AG

Ready-to-fill, i.e. sterile, prefillable glass syringes, are washed, siliconized, sterilized and packaged by the primary packaging manufacturer. They can then be filled by the pharmaceutical companies without any further processing. These days the majority of prefillable syringes are made of glass and the trend looks set to continue. The siliconization of the syringe barrel is an extremely important aspect of the production of sterile, prefillable glass syringes because the functional interaction of the glass barrel siliconization and the plunger stopper siliconization is crucial to the efficiency of the entire system. Both inadequate and excessive siliconization can cause problems in this connection. The use of modern technology can achieve an extremely uniform distribution of silicone oil in glass syringes with reduced quantities of silicone oil. Another option for minimizing the amount of free silicone oil in a syringe is the thermal fixation of the silicone oil on the glass surface in a process called baked-on siliconization. Plastic-based silicone oil-free or low-silicone oil prefillable syringe systems are a relatively new development. Silicone oil-free lubricant coatings for syringes are also currently in the development phase.
More info >>

Industry Events

SAPHEX 2018

1-2 November 2018, Gallagher Convention Centre, Midrand, South Africa

The SAPHEX exhibition and conference is now established as the “go-to” networking and business event for anyone working in the South African pharmaceutical manufacturing industry.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement